Entry - #620253 - CATARACT 50 WITH OR WITHOUT GLAUCOMA; CTRCT50 - OMIM
 
# 620253

CATARACT 50 WITH OR WITHOUT GLAUCOMA; CTRCT50


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
9q21.12-q21.13 ?Cataract 50 with or without glaucoma 620253 AD 3 TRPM3 608961
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
HEAD & NECK
Eyes
- Cataract
- Glaucoma, high-tension
- Persistent pupillary membrane (in some patients)
- Retinal detachment (in some patients)
MISCELLANEOUS
- Intrafamilial variability
- Over half of patients with cataract also have glaucoma
- Age of diagnosis of cataract ranges from birth to fourth decade
- Age of diagnosis of glaucoma ranges from birth to fifth decade
MOLECULAR BASIS
- Caused by mutation in the transient receptor potential cation channel, subfamily M, member-3 gene (TRPM3, 608961.0002)
Cataract - PS116200 - 51 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1pter-p36.13 Cataract 8, multiple types AD 2 115665 CTRCT8 115665
1p36.32 ?Cataract 49 AD 3 619593 PANK4 606162
1p36.13 Cataract 6, multiple types AD 3 116600 EPHA2 176946
1p33 Cataract 34, multiple types AR 3 612968 FOXE3 601094
1q21.2 Cataract 1, multiple types AD 3 116200 GJA8 600897
2pter-p24 Cataract 29, coralliform AD 2 115800 CTRCT29 115800
2p12 Cataract 27, nuclear progressive 2 607304 CTRCT27 607304
2q33.3 Cataract 4, multiple types AD 3 115700 CRYGD 123690
2q33.3 Cataract 2, multiple types AD 3 604307 CRYGC 123680
2q33.3 Cataract 39, multiple types, autosomal dominant AD 3 615188 CRYGB 123670
2q35 ?Cataract 42 AD 3 115900 CRYBA2 600836
3p21.31 Cataract 18, autosomal recessive AR 3 610019 FYCO1 607182
3q22.1 Cataract 12, multiple types AD 3 611597 BFSP2 603212
3q27.3 Cataract 20, multiple types AD 3 116100 CRYGS 123730
4p16.1 ?Cataract 41 AD 3 116400 WFS1 606201
6p24.3-p24.2 Cataract 13 with adult i phenotype AR 3 116700 GCNT2 600429
6p21.31 Cataract 46, juvenile-onset AR 3 212500 LEMD2 616312
6p12-q12 {Cataract 28, age-related cortical, susceptibility to} 2 609026 CTRCT28 609026
7q34 Cataract 38, autosomal recessive AR 3 614691 AGK 610345
9q13-q22 Cataract 26, multiple types 2 605749 CTRCT26 605749
9q21.12-q21.13 ?Cataract 50 with or without glaucoma AD 3 620253 TRPM3 608961
9q22.33 Cataract 36 AR 3 613887 TDRD7 611258
10p13 Cataract 30, pulverulent AD 3 116300 VIM 193060
10q23.31 Cataract 47, juvenile, with microcornea AD 3 612018 SLC16A12 611910
10q24.2 Cataract 48 AR 3 618415 DNMBP 611282
10q24.32 Cataract 11, syndromic, autosomal recessive AD, AR 3 610623 PITX3 602669
10q24.32 Cataract 11, multiple types AD, AR 3 610623 PITX3 602669
11q23.1 Cataract 16, multiple types AD, AR 3 613763 CRYAB 123590
12q13.3 Cataract 15, multiple types AD 3 615274 MIP 154050
12q24.2-q24.3 Cataract 37, autosomal dominant AD 2 614422 CTRCT37 614422
13q12.11 Cataract 14, multiple types AD 3 601885 GJA3 121015
14q22-q23 Cataract 32, multiple types AD 2 115650 CTRCT32 115650
15q21-q22 Cataract 25 2 605728 CTRCT25 605728
16q22.1 Cataract 5, multiple types AD 3 116800 HSF4 602438
16q23.2 Cataract 21, multiple types AD 3 610202 MAF 177075
17p13 Cataract 24, anterior polar AD 2 601202 CTRCT24 601202
17q11.2 Cataract 10, multiple types AD 3 600881 CRYBA1 123610
17q12 ?Cataract 43 AD 3 616279 UNC45B 611220
17q24 Cataract 7 AD 2 115660 CTRCT7 115660
19q13 Cataract 35, congenital nuclear AR 2 609376 CTRCT35 609376
19q13.13-q13.2 ?Cataract 45 AR 3 616851 SIPA1L3 616655
19q13.41 Cataract 19, multiple types AD, AR 3 615277 LIM2 154045
20p12.1 Cataract 33, multiple types AD, AR 3 611391 BFSP1 603307
20q11.22 Cataract 31, multiple types AD 3 605387 CHMP4B 610897
21q22.3 Cataract 9, multiple types AD, AR 3 604219 CRYAA 123580
21q22.3 Cataract 44 AR 3 616509 LSS 600909
22q11.23 Cataract 22 AD, AR 3 609741 CRYBB3 123630
22q11.23 Cataract 3, multiple types AD 3 601547 CRYBB2 123620
22q12.1 Cataract 23 AD 3 610425 CRYBA4 123631
22q12.1 Cataract 17, multiple types AD, AR 3 611544 CRYBB1 600929
Xp22.2-p22.13 Cataract 40, X-linked XL 3 302200 NHS 300457

TEXT

A number sign (#) is used with this entry because of evidence that cataract-50 with or without glaucoma (CTRCT50) is caused by heterozygous mutation in the TRPM3 gene (608961) on chromosome 9q21. One such family has been reported.


Description

CTRCT50 is characterized by pediatric or early-onset cataract, with more than half of affected individuals exhibiting high-tension glaucoma. Variable anterior segment defects have also been reported (Bennett et al., 2014).


Clinical Features

Bennett et al. (2014) reported a large 5-generation Caucasian American family segregating autosomal dominant cataract with or without glaucoma and with mutation in the TRPM3 gene. The family was ascertained through medical records, and retrospective review of those records revealed that of 25 individuals over 4 generations who were considered affected, 15 (60%) had cataract and glaucoma, 9 had cataract without glaucoma, and a 24-year-old woman had only persistent pupillary membrane. In addition, a 7-year-old boy, whose twin brother had unilateral cataract, was undiagnosed, and an 8-year-old girl who did not undergo genetic testing had infantile glaucoma without cataract, as well as anterior segment dysgenesis, megalocornea, corectopia, and persistent pupillary membrane. Three patients had persistent pupillary membrane, and 3 patients had retinal detachment. All family members with cataract had visually significant lens opacities and underwent lens extraction. Cataract was usually bilateral, and age at diagnosis ranged from birth to 35 years, with age at first surgery ranging from 4 to 40 years. Slit-lamp images of cataracts were not available; however, opacities had been described as punctate cortical in 1 patient and posterior subcapsular in another. A diagnosis of glaucoma was made based on significantly elevated intraocular pressure (greater than 30 mmHg) and in some cases was accompanied by visual field and/or optic nerve abnormalities; age at diagnosis ranged from birth into the fifth decade.


Inheritance

The transmission pattern of CTRCT50 in a large 5-generation family reported by Bennett et al. (2014) was consistent with autosomal dominant inheritance.


Mapping

In affected members of a large 5-generation family with autosomal dominant cataract with or without glaucoma, who were negative for mutation in genes encoding ocular transcription factors and other candidate genes, Bennett et al. (2014) performed genomewide linkage analysis and detected significant evidence of linkage on chromosome 9q. Haplotype analysis defined a 46-Mb common disease interval spanning the pericentric region that cosegregated with disease in all affected relatives. After analysis of recombination events, the authors narrowed the disease interval to a 39.7-Mb interval between markers rs2073478 and D9S284, noting that it excluded the adjacent locus for autosomal recessive pulverulent cataract (CTRCT26; 605749) and the cataract (CTRCT36; 613887)-associated gene TDRD7 (611258).


Molecular Genetics

In affected members of a large 5-generation family autosomal dominant cataract with or without glaucoma mapped to chromosome 9q, Bennett et al. (2014) performed exome sequencing and identified a heterozygous missense mutation in the TRPM3 gene (I65M; 608961.0002). The variant segregated fully with disease in the family and was not found in 192 unrelated controls or in the 1000 Genomes Project or EVS databases.


Animal Model

Using CRISPR/Cas9 gene editing technology, Zhou et al. (2021) generated knock-in mice with the TRPM3 cataract-associated I65M mutation (608961.0002) and compared them to Trpm3-null mice, noting that the null mice exhibited only mild impairment of lens growth, whereas Trpm3 M/M homozygotes developed severe progressive anterior pyramid-like cataract with microphthalmia. In addition, heterozygous Trpm3 I/M and hemizygous Trpm3 M/- mutants developed anterior pyramidal cataract with delayed onset, consistent with a semidominant lens phenotype. Histochemical staining revealed abnormal accumulation of calcium phosphate-like deposits and collagen fibrils in Trpm3-mutant lenses, and immunoblotting detected increased alpha-II-spectrin (SPTAN1; 182810) cleavage products consistent with calpain (see 114220) hyperactivation. Immunofluorescence confocal microscopy of Trpm3-M/M mutant lenses revealed fiber cell membrane degeneration that was accompanied by accumulation of alpha-smooth muscle actin (see 102620)-positive myofibroblast-like cells and macrosialin (CD68; 153634)-positive macrophage-like cells. The authors concluded that Trpm3 deficiency impairs lens growth but not lens transparency, and that Trpm3 dysfunction results in progressive lens degeneration and calcification, coupled with profibrotic and immune cell responses.


REFERENCES

  1. Bennett, T. M., Mackay, D. S., Siegfried, C. J., Shiels, A. Mutation of the melastatin-related cation channel, TRPM3, underlies inherited cataract and glaucoma. PLoS One 9: e104000, 2014. [PubMed: 25090642, images, related citations] [Full Text]

  2. Zhou, Y., Bennett, T. M., Shiels, A. Mutation of the TRPM3 cation channel underlies progressive cataract development and lens calcification associated with pro-fibrotic and immune cell responses. FASEB J. 35: e21288, 2021. [PubMed: 33484482, images, related citations] [Full Text]


Creation Date:
Marla J. F. O'Neill : 02/17/2023
carol : 02/20/2023
carol : 02/17/2023

# 620253

CATARACT 50 WITH OR WITHOUT GLAUCOMA; CTRCT50


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
9q21.12-q21.13 ?Cataract 50 with or without glaucoma 620253 Autosomal dominant 3 TRPM3 608961

TEXT

A number sign (#) is used with this entry because of evidence that cataract-50 with or without glaucoma (CTRCT50) is caused by heterozygous mutation in the TRPM3 gene (608961) on chromosome 9q21. One such family has been reported.


Description

CTRCT50 is characterized by pediatric or early-onset cataract, with more than half of affected individuals exhibiting high-tension glaucoma. Variable anterior segment defects have also been reported (Bennett et al., 2014).


Clinical Features

Bennett et al. (2014) reported a large 5-generation Caucasian American family segregating autosomal dominant cataract with or without glaucoma and with mutation in the TRPM3 gene. The family was ascertained through medical records, and retrospective review of those records revealed that of 25 individuals over 4 generations who were considered affected, 15 (60%) had cataract and glaucoma, 9 had cataract without glaucoma, and a 24-year-old woman had only persistent pupillary membrane. In addition, a 7-year-old boy, whose twin brother had unilateral cataract, was undiagnosed, and an 8-year-old girl who did not undergo genetic testing had infantile glaucoma without cataract, as well as anterior segment dysgenesis, megalocornea, corectopia, and persistent pupillary membrane. Three patients had persistent pupillary membrane, and 3 patients had retinal detachment. All family members with cataract had visually significant lens opacities and underwent lens extraction. Cataract was usually bilateral, and age at diagnosis ranged from birth to 35 years, with age at first surgery ranging from 4 to 40 years. Slit-lamp images of cataracts were not available; however, opacities had been described as punctate cortical in 1 patient and posterior subcapsular in another. A diagnosis of glaucoma was made based on significantly elevated intraocular pressure (greater than 30 mmHg) and in some cases was accompanied by visual field and/or optic nerve abnormalities; age at diagnosis ranged from birth into the fifth decade.


Inheritance

The transmission pattern of CTRCT50 in a large 5-generation family reported by Bennett et al. (2014) was consistent with autosomal dominant inheritance.


Mapping

In affected members of a large 5-generation family with autosomal dominant cataract with or without glaucoma, who were negative for mutation in genes encoding ocular transcription factors and other candidate genes, Bennett et al. (2014) performed genomewide linkage analysis and detected significant evidence of linkage on chromosome 9q. Haplotype analysis defined a 46-Mb common disease interval spanning the pericentric region that cosegregated with disease in all affected relatives. After analysis of recombination events, the authors narrowed the disease interval to a 39.7-Mb interval between markers rs2073478 and D9S284, noting that it excluded the adjacent locus for autosomal recessive pulverulent cataract (CTRCT26; 605749) and the cataract (CTRCT36; 613887)-associated gene TDRD7 (611258).


Molecular Genetics

In affected members of a large 5-generation family autosomal dominant cataract with or without glaucoma mapped to chromosome 9q, Bennett et al. (2014) performed exome sequencing and identified a heterozygous missense mutation in the TRPM3 gene (I65M; 608961.0002). The variant segregated fully with disease in the family and was not found in 192 unrelated controls or in the 1000 Genomes Project or EVS databases.


Animal Model

Using CRISPR/Cas9 gene editing technology, Zhou et al. (2021) generated knock-in mice with the TRPM3 cataract-associated I65M mutation (608961.0002) and compared them to Trpm3-null mice, noting that the null mice exhibited only mild impairment of lens growth, whereas Trpm3 M/M homozygotes developed severe progressive anterior pyramid-like cataract with microphthalmia. In addition, heterozygous Trpm3 I/M and hemizygous Trpm3 M/- mutants developed anterior pyramidal cataract with delayed onset, consistent with a semidominant lens phenotype. Histochemical staining revealed abnormal accumulation of calcium phosphate-like deposits and collagen fibrils in Trpm3-mutant lenses, and immunoblotting detected increased alpha-II-spectrin (SPTAN1; 182810) cleavage products consistent with calpain (see 114220) hyperactivation. Immunofluorescence confocal microscopy of Trpm3-M/M mutant lenses revealed fiber cell membrane degeneration that was accompanied by accumulation of alpha-smooth muscle actin (see 102620)-positive myofibroblast-like cells and macrosialin (CD68; 153634)-positive macrophage-like cells. The authors concluded that Trpm3 deficiency impairs lens growth but not lens transparency, and that Trpm3 dysfunction results in progressive lens degeneration and calcification, coupled with profibrotic and immune cell responses.


REFERENCES

  1. Bennett, T. M., Mackay, D. S., Siegfried, C. J., Shiels, A. Mutation of the melastatin-related cation channel, TRPM3, underlies inherited cataract and glaucoma. PLoS One 9: e104000, 2014. [PubMed: 25090642] [Full Text: https://doi.org/10.1371/journal.pone.0104000]

  2. Zhou, Y., Bennett, T. M., Shiels, A. Mutation of the TRPM3 cation channel underlies progressive cataract development and lens calcification associated with pro-fibrotic and immune cell responses. FASEB J. 35: e21288, 2021. [PubMed: 33484482] [Full Text: https://doi.org/10.1096/fj.202002037R]


Creation Date:
Marla J. F. O'Neill : 02/17/2023

Edit History:
carol : 02/20/2023
carol : 02/17/2023